How do we manage cardiopulmonary bypass coagulopathy?

Kerry J. Welsh, Elena Nedelcu, Yu Bai, Amer Wahed, Kimberly Klein, Hlaing Tint, Igor Gregoric, Manish Patel, Biswajit Kar, Pranav Loyalka, Sriram Nathan, Paul Loubser, Phillip A. Weeks, Rajko Radovancevic, Andy N D Nguyen

Research output: Contribution to journalArticle

12 Scopus citations

Abstract

BACKGROUND: Patients who undergo cardiopulmonary bypass (CPB) are at risk for coagulopathy. Suboptimal turnaround time (TAT) of laboratory coagulation testing results in empiric administration of blood products to treat massive bleeding. We describe our initiative in establishing the coagulation-based hemotherapy (CBH) service, a clinical pathology consultation service that uses rapid TAT coagulation testing and provides comprehensive assessment of bleeding in patients undergoing CPB. A transfusion algorithm that treats the underlying cause of coagulopathy was developed. STUDY DESIGN AND METHODS: The coagulation testing menu includes all aspects of coagulopathy with close proximity of the laboratory to the operating room to allow for rapid test results. The hemotherapy pathologist monitors laboratory results at several stages in surgery and uses a comprehensive algorithm to monitor a patient's hemostasis. The optimal number and type of blood products are selected when the patient is taken off CPB. RESULTS: The CBH service was consulted for 44 ventricular assist device implants, 30 heart transplants, and 31 other cardiovascular surgeries from May 2012 through November 2013. The TAT for laboratory tests was 15 minutes for complete blood count, antithrombin, and coagulation panel and 30 minutes for VerifyNow and thromboelastography, in comparison to 45 to 60 minutes in normal settings. The transfusion algorithms were used with optimal administration of blood components with preliminary data suggestive of reduced blood product usage and better patient outcomes. CONCLUSION: We described the successful introduction of a novel pathology consultation service that uses a rapid TAT coagulation testing menu with transfusion algorithms for improved management of CPB patients.

Original languageEnglish (US)
Pages (from-to)2158-2166
Number of pages9
JournalTransfusion
Volume54
Issue number9
DOIs
StatePublished - 2014
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Immunology
  • Immunology and Allergy
  • Medicine(all)

Fingerprint Dive into the research topics of 'How do we manage cardiopulmonary bypass coagulopathy?'. Together they form a unique fingerprint.

  • Cite this

    Welsh, K. J., Nedelcu, E., Bai, Y., Wahed, A., Klein, K., Tint, H., Gregoric, I., Patel, M., Kar, B., Loyalka, P., Nathan, S., Loubser, P., Weeks, P. A., Radovancevic, R., & Nguyen, A. N. D. (2014). How do we manage cardiopulmonary bypass coagulopathy? Transfusion, 54(9), 2158-2166. https://doi.org/10.1111/trf.12751